Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000042

Options or other derivatives

  • EVP, Chief Business Officer acquired 28,839 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table II: Derivative

3 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2023-01-15 Grant or award : show line 1 in the form Performance Restricted Stock Units +12,290 $0.00 12,290 12,290 D
2023-01-15 Grant or award : show line 2 in the form Restricted Stock Unit +14,749 $0.00 14,749 58,099 D
2023-01-15 Grant or award : show line 3 in the form Restricted Stock Unit +1,800 $0.00 1,800 4,866 I
Loading xslF345X03/edgardoc.xml…